Exsure Private Limited

Exsure Private Limited At ExSURE, we are developing a unique exosome-based targeted drug delivery platform that effectively eliminates cancer cells and cancer stem cells.

Bio-engineered exosomes will be harnessed from immune cells that will precisely target tumors.

We are excited to announce that we are hiring ! Interested candidates please do share your LinkedIn profile link along w...
09/04/2025

We are excited to announce that we are hiring ! Interested candidates please do share your LinkedIn profile link along with your CV !

21/03/2025
EXOSURE gives you purified exosomes within just 24 hours!No contamination from other EVsNo need for hectic Ultracentrifu...
27/01/2025

EXOSURE gives you purified exosomes within just 24 hours!
No contamination from other EVs
No need for hectic Ultracentrifugation steps !
EXOSURE is used to develop EXODS (our patented technology, Exosome Optimized Drug Delivery System) at the lab-scale by Team Exsure.
EXOSURE gives purified EXODS for Non-clinical studies carried out in partnership with non-clinical CRO in India

As Exosome-based studies rapidly increase, try out EXOSURE (2-in-1 exosome isolation reagent) manufactured by Exsure in-house. Tested and validated by researchers Pan India! We are available in two-pack sizes.

Try and give us your feedback !

23/01/2025

💊 ExSURE PVT. LTD.: Transforming cancer treatment with exosome-based drug delivery 🌟 We’re proud to announce our investment in Exsure, a groundbreaking biotech company revolutionizing cancer therapy. Exsure’s ExoDS platform delivers chemotherapy drugs directly to tumor cells, enabling prec...

23/01/2025

Bhubaneswar based biotech startup Exsure has raised Rs 3 crore in a seed round led by Unicorn India Ventures. The funds raised will be used to complete the milestones of non-clinical study with its exosome-based drug delivery vehicle and will also support Exsure’s global expansion plan with i...

23/01/2025

Investment In Biotech: The biotech startup aims to reduce the side effects of anti-cancer drugs through its innovative drug-delivery platform. With this funding, it plans to complete its non-clinical study by year-end and present its data to CDSCO.

Address

KIIT TBI, Campus-11, Room No. 301, KIIT UNIVERSITY, Patia, Khordha, Odisha
Bhubaneswar
751024

Telephone

+917980402341

Alerts

Be the first to know and let us send you an email when Exsure Private Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Exsure Private Limited:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram